ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1380

Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus

Rebecca Sadun1, Laura Lewandowski2, Alexandre Belot3, Eve Smith4 and Jennifer Cooper5, 1Duke University, Durham, NC, 2NIAMS, NIH, Bethesda, MD, 3Hospices Civils de Lyon, Collonges au mont d'or, France, 4University of Liverpool, Liverpool, United Kingdom, 5University of Colorado/Children's Hospital Colorado, Denver, CO

Meeting: ACR Convergence 2022

Keywords: Disease Activity, Pediatric rheumatology, registry, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) occurs in approximately 20% of all SLE cases. cSLE is has a worse prognosis than adult-onset SLE, often requiring more aggressive therapy. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) coordinates a collaborative cSLE registry for patients in the US and Canada. Additional registries capture cSLE data in the United Kingdom (UK JSLE Registry) and throughout Europe (JIR Registry). To date, differences in data fields and collection methodology have been barriers to collaborative inter-registry research, whereas inter-registry research would enhance patient numbers and improve research quality. Our aim was to develop two standardized datasets to facilitate international registry-based cSLE research. Firstly, a minimum “core” dataset that would be feasible for SLE research at centers without data entry support, and secondly an “expanded” dataset that is more comprehensive and designed for use in centers with more established research infrastructure.

Methods: SLE experts (15 pediatric rheumatologists, 4 combined pediatric and adult rheumatologists, 2 pediatric nephrologists) with international representation (10 countries; 5 continents) participated in two Delphi questionnaires followed by an 8-hour virtual consensus meeting. Four patients/caregivers also attended the virtual consensus meeting with equal votes. Final data elements for the core and expanded datasets were determined using adapted nominal group technique and voting, with consensus requiring ³ 80% agreement.

Results: Twenty (95%) experts responded to the first Delphi questionnaire and 21 (100%) to the second questionnaire. Twenty-one physicians and 4 patients/caregivers attended the consensus meeting, all with equal votes. The group achieved consensus for core (Table 1) and expanded (Table 2) data elements in the following areas: demographics, SLE history, co-morbidities, family history, SLE classification criteria, visit data, laboratory testing, kidney biopsy data, disease activity measurements, damage index, medications, and serious adverse events. In addition, consensus was achieved regarding frequency of data collection (every 3 months + flare visits).

Conclusion: Standardized core and expanded datasets for registry-based international cSLE research were defined by global expert consensus. These datasets consider unique aspects of children with SLE in a range of geographic and resourced settings. The core and expanded datasets will facilitate international collaborative research for children and adolescents with SLE worldwide.

Supporting image 1

Supporting image 2


Disclosures: R. Sadun, None; L. Lewandowski, None; A. Belot, SOBI, Novartis, Roche, Pfizer; E. Smith, None; J. Cooper, None.

To cite this abstract in AMA style:

Sadun R, Lewandowski L, Belot A, Smith E, Cooper J. Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/development-of-core-and-expanded-datasets-to-align-registries-and-advance-international-collaborative-research-for-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-core-and-expanded-datasets-to-align-registries-and-advance-international-collaborative-research-for-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology